Core One Labs Stock Price, News & Analysis
Company Description
Core One Labs (OTC Link: CLABF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $4.9M.
CLABF stock has declined 100.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of CLABF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Core One Labs (CLABF) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $4.9M, CLABF is classified as a micro-cap stock with approximately 47.1M shares outstanding.
Latest News
Core One Labs has 10 recent news articles. Of the recent coverage, 9 articles coincided with positive price movement and 1 with negative movement. View all CLABF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Core One Labs (CLABF) currently stands at 2 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Core One Labs (CLABF) currently stands at 1000.0 days, up 99899% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 99899% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
CLABF Company Profile & Sector Positioning
Core One Labs (CLABF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CLABF often look at related companies in the same sector, including Orgenesis Inc (ORGS), Vaxxinity, Inc. (VAXX), Kane Biotech Inc (KNBIF), Sigyn Therapeutics Inc (SIGY), and Biophytis Sa (BPTSY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CLABF's relative position within its industry.